经过两侧交叉导管边缘到边缘修复后不同风险预测工具的比较分析
Mauricio Felippi de Sá Marchi1, Mark van den Dorpel2, Pedro Calomeni3
1Department of Interventional Cardiology, Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands; Department of Interventional Cardiology, Heart Institute (InCor), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, Brazil.
International journal of cardiology
|January 11, 2024
概括
MITRALITY风险评分最好预测1年死亡率和心力衰竭住院治疗后跨导管边缘到边缘修复 (TEER). 在这项研究中,其他得分的预测值很差.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗器械 医疗器械
背景情况:
- 过导管边缘到边缘修复 (TEER) 是对初级和二级心肌反 (PMR和SMR) 的关键治疗方法.
- 准确的风险分层对于优化患者选择和TEER后的结果至关重要.
研究的目的:
- 为了比较1年死亡率和TEER后复合终点的各种风险得分的预测准确性.
- 评估PMR/SMR组合种群和仅SMR的子组的风险评分.
主要方法:
- 在2011-2023年期间,对206名患者进行了TEER治疗以治疗 mitrale regurgitation (MR) 的分析.
- 欧罗斯科尔II,GRASP,MITRALITY,MitraScore,TAPSE/PASP-MitraScore和STS分数的比较. 这些分数包括:
- 亚分析包括SMR患者的COAPT风险评分和NT-proBNP.
主要成果:
- 在PMR/SMR组合中,MITRALITY在1年死亡率 (AUC 0.74) 和复合终点 (AUC 0.74) 中表现出最高的区分能力.
- 在仅SMR的小组中,MITRALITY还显示出1年死亡率 (AUC 0.72) 和复合终点 (AUC 0.72) 的最佳预测性能.
结论:
- 利性成为预测1年死亡率和TEER后HF住院的优越风险模型.
- 传统的外科风险评分,MitraScore,TAPSE/PASP-MitraScore和NT-proBNP单独显示出有限的预测价值.
相关概念视频
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...